Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Please help us personalize your experience.

Select the one that best describes you
Etfdb logo
  • ETF
  • FV
    Pricing Data
    Change: $0.01 (0.0%)
    Time: 07/16/18
    Previous Close: $30.54
  • Category
  • Large Cap Growth Equities
Last Updated:



Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $24.57
  • 52 Week Hi: $31.01
  • AUM: $2,791.6 M
  • Shares: 91.4 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 239,843
  • 3 Month Avg. Volume: 223,941

Alternative ETFs in the Large Cap Growth Equities Category

Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

Top Posts

renminbi vs us dollar isrg google finance etfs natural gas safest etf fidelity russell 2000 index fund us saving bonds gov euro equity hedge tracker fdesx dollar in swiss francs mutual funds returns comparison india nat ticker

Realtime Rating

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for FV on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Large Cap Growth Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a . To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

FV Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A n/a
Expenses C n/a

Knowledge Centers

FV In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its Category.

FV Holdings

Filings Data as of: Jul 13, 2018

All 6 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group Category.

Number of Holdings
Category Low
Category High
% Assets in Top 10
Category Low
Category High

Asset Allocation

Asset Percentage
Common equity 99.83%
ETF Cash Component 0.17%

Sector Breakdown

Sector Percentage
Technology 55.93%
Financials 19.64%
Industrials 16.15%
Consumer, Cyclical 5.46%
Healthcare 1.0%
Other 0.85%
Telecommunications 0.79%
ETF Cash Component 0.17%

Market Cap Breakdown

Market Cap Percentage
Large cap 59.65%
Mid cap 31.16%
Small cap 8.44%
Micro cap 0.58%
ETF Cash Component 0.17%

Region Breakdown

Region Percentage
North America 95.94%
Europe 1.9%
Asia 1.23%
Middle East 0.59%
Latin America 0.34%

Market Tier Breakdown

Region Percentage
United States 95.64%
Developed Markets (ex-US) 2.79%
Emerging Markets 1.23%
Not-designated 0.34%

Country Breakdown

Country Percentage
United States 95.64%
China 1.09%
Ireland 0.94%
Israel 0.59%
Netherlands 0.57%
United Kingdom 0.4%
Panama 0.34%
Canada 0.3%
India 0.13%

FV Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same Category.

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 0 other ETFs in the Large Cap Growth Equities Category that are also eligible for commission free trading:

  • Ticker Brokerages

FV Performance

This section shows how this ETF has performed relative to its peer group Category.

1 Week Return
Category Low
Category High
4 Week Return
Category Low
Category High
13 Week Return
Category Low
Category High
26 Week Return
Category Low
Category High
Year to Date Return
Category Low
Category High
1 Year Return
Category Low
Category High
3 Year Return
Category Low
Category High
5 Year Return
No Ranking Available
Category Low
Category High

FV Fund Flows

This section compares the fund flows of this ETF to peers in the same Category.

1 Week Fund Flow
$10.6 M
Category Low
Category High
4 Week Fund Flow
$49.6 M
Category Low
Category High
13 Week Fund Flow
$88.4 M
Category Low
Category High
26 Week Fund Flow
‑$0.2 M
Category Low
Category High
Year to Date Fund Flow
$61.8 M
Category Low
Category High
1 Year Fund Flow
‑$112.8 M
Category Low
Category High
3 Year Fund Flow
‑$1,427.8 M
Category Low
Category High
5 Year Fund Flow
No Ranking Available
Category Low
Category High

Brought to You by Mitre Media


The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of FV relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

FV Valuation

This section shows how the P/E multiple of this ETF compares to the peer group Category.

P/E Ratio
Category Low
Category High

FV Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group Category.

5 Day Volatility
Category Low
Category High
20 Day Volatility
Category Low
Category High
50 Day Volatility
Category Low
Category High
200 Day Volatility
Category Low
Category High
Category Low
Category High
Standard Deviation
Category Low
Category High


  • 20 Day MA: $30.15
  • 60 Day MA: $29.87
  • MACD 15 Period: 0.58
  • MACD 100 Period: 0.90
  • Williams % Range 10 Day: 8.50
  • Williams % Range 20 Day: 23.44
  • RSI 10 Day: 58
  • RSI 20 Day: 56
  • RSI 30 Day: 55
  • Ultimate Oscillator: 63

Bollinger Brands

  • Lower Bollinger (10 Day): $29.42
  • Upper Bollinger (10 Day): $30.95
  • Lower Bollinger (20 Day): $29.17
  • Upper Bollinger (20 Day): $31.13
  • Lower Bollinger (30 Day): $29.36
  • Upper Bollinger (30 Day): $31.29

Support & Resistance

  • Support Level 1: n/a
  • Support Level 2: $30.37
  • Resistance Level 1: n/a
  • Resistance Level 2: $30.77


  • Stochastic Oscillator %D (1 Day): 51.91
  • Stochastic Oscillator %D (5 Day): 78.62
  • Stochastic Oscillator %K (1 Day): 58.72
  • Stochastic Oscillator %K (5 Day): 78.66

Fact Sheet

Fact sheets are issued by the ETF provider and framed by Information contained within the fact sheet is not guaranteed to be timely or accurate.

Emma/Mansi Image

Published March 1, 2016

The following article was not written by a human. It was written by an AI called Emma. Her bio can be found on her author page.

Artificial intelligence has come a long way, and while it may or may not replace humans, it is already providing exceptional support by augmenting human work in many industries. Emma collates news items and analyzes structured financial numbers as she spins out an article in 20 minutes. This is definitely an interesting milestone in AI. We’re just checking in to see if our readers like it. Do give us a shout on Twitter at @ETFdb or on Facebook.

Significant Exposure to Health Care

The First Trust Dorsey Wright Focus 5 ETF (FV C+) corresponds to the price and yield of the Dorsey Wright Focus Five Index. The fund will invest at least 90% of its net assets in ETFs that compose the index. The index is designed to provide targeted exposure to the five First Trust sector­-based ETFs that the index issuer believes offer the greatest potential to outperform the other ETFs. The index selects five ETFs based on relative price momentum and weights the constituent ETFs equally.

FV offers significant exposure to health care and consumer companies; health care accounts for more than 33% of exposure, while consumer names account for almost 40%. This means the ETF is prone to regulatory changes on the health care side ­as it relates to HMOs, Big Pharma and biotech. At the same time, the consumer names are impacted by global monetary policy. Over the course of the last 12 months, biotech, which is typically among the best performers in the health care sector, has seen its momentum slow.

This can be attributed to a variety of factors such as the exposé on Valeant, an increased regulatory focus on drug pricing in the U.S., and generic drug manufacturers outside the U.S. eating away market share, leaving little wiggle room for Big Pharma. The global consumer, meanwhile, remains resilient. However, significant headwinds in the form of slowing demand in China, rising interest rates in the U.S., a strong dollar, and a negative interest rate policy adopted by the ECB and the Japanese central bank have all been a drag on corporate earnings worldwide.

Political Rhetoric Against FV

The macro picture for FV is negative. Let’s look at several points worth considering. This year is an election year, and for some of FV’s constituents in the health care sector, the U.S. is by far the biggest market. With political rhetoric against FV’s largest constituents, ­owing to regulatory oversight on drug pricing, relationships with pharma retailers, and competition from generics, it appears that pre-election 2016 will bring a repeat of last year’s performance. While consumer names like Amazon (AMZN) and other sectors such as financials will probably offset some of the losses caused by the health care industry, the relative exposure of FV to health care is too large to ignore.

That takes us to FV’s financial ratios. FV has $3.4 billion in assets under management and has a yield of 0.16%, which is below market average. The ETF is at the midpoint of its all-time high of $25.51 and its all-time low of $17.75, hit in April 2014, just when it began trading. The fund’s expense ratio is 0.89%, which is significantly higher than other funds in its category. FV has a turnover ratio of 0%.

Weak Sell

I believe there are other opportunities in specific companies to which FV offers exposure. Given the lack of historical performance, an unclear theme, a recent runup, fees, and the headline risks, ­FV will be attractive below $20. With FV right now at $21.28, I believe it is a Weak Sell with a price target of $20.50.

Click here to read about Emma’s views on Microsoft, the ETFs QQQ, GDX, TLT, VOO and VTI, and the ETNs TVIX and VXX.

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at